MUTIERTE IMMUNGLOBULINBINDENDE POLYPEPTIDE

European patent · EP3019520 · Deleted

Register entry

Publication number
EP3019520
Application number
EP14823829
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 8, 2014
Published
May 18, 2016
Granted
Dec 11, 2019
Deleted
Jul 31, 2020
Reason
Annual fee unpaid
IPC classes
C07K 14/31 (2006.01)
B01D 15/38 (2006.01)
C07K 1/22 (2006.01)
C12N 15/00 (2006.01)
Priority
SE 1350860 10.07.2013
SE 1350859 10.07.2013
PCT application
PCT/SE2014/050872 08.07.2014
PCT publication
WO2015/005859 15.01.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 17, 2021

    Deleted, fee unpaid

    Published in Swissreg on 17.02.2021

  2. Jul 16, 2020

    Owner

    Owner
    GE Healthcare BioProcess R&D AB, Björkgatan 30, 751 84 Uppsala, Sweden → Cytiva BioProcess R&D AB, Björkgatan 30, 751 84 Uppsala, Sweden

    Published in Swissreg on 16.07.2020

  3. Dec 11, 2019

    Granted

    Published in Swissreg on 11.12.2019

Parties

Holder

Cytiva BioProcess R&D AB

Björkgatan 30, 751 84 Uppsala, SE

Inventor

ANDER, Mats

S-751 84 Uppsala, SE

RODRIGO, Gustav

S-751 84 Uppsala, SE

BAURÉN, Göran

S-751 84 Uppsala, SE

BJÖRKMAN, Tomas

S-751 84 Uppsala, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.